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INTRODUCTION 
Influenza and other acute respiratory infections are the 
most large-scale diseases that occupy the leading place in 
the structure of infectious diseases and constitute up to 
80-90% of all cases of infectious pathology [1]. According 
to WHO estimates, each year, influenza globally afflicts up 
to 500 million people, 2 million of whom die. The highest 
number of fatal cases in influenza is due to complications, 
the leading place (80-90%) among which belongs to pneu-
monia [2], that develops mainly in patients at risk (pregnant 
women, patients with diabetes, obesity, chronic diseases of 
the lungs and heart, people of senior age groups, etc.) [3, 
4]. However, according to WHO, 30% of patients who were 
previously considered healthy may also have severe and 
complicated influenza, which necessitates further study of 
factors affecting the course and sequelae of the disease [4]. 
It is known that the individual susceptibility of the body 
to infections is determined by pathogenicity of a micro-
organism, factors of the environment and the state of the 
immune system. It is the innate immune system that plays 
a crucial role in protecting the body from pathogens whose 
recognition is based on the Toll-like (TLR) receptor family. 
Excitation of TLR during the infection of the respiratory 
tract leads to the activation of genes involved in the regu-
lation of the inflammatory process, the innate mechanisms 
of protection against infectious agents, acquired immunity 
[5]. The genes that control the type of immune response, 
the sensitivity/resistance to the influenza, the propensity 
to various forms of the course and development of com-
plications, include primarily the TLR-2, TLR-3, and TLR-4 
genes [6]. These receptors are involved in the recognition 
of the viral structural proteins and ligands of gram-positive 
and gram-negative bacteria (TLR-2 and TLR-4), as well as 
of dlRNA, which is the product of replication and transcrip-
tion of RNA- and DNA-genomic viruses (TLR-3) [7-9]. 
Recent studies have shown that the TLR dysfunction, as-
sociated with the polymorphism of their genes, leads to the 
disturbance in the recognition of pathogens and imbalance 
in the functioning of the congenital immunity system, thus 
increasing the sensitivity to infections and determining the 
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The aim of the research is to study the prevalence and to determine the prognostic significance of polymorphism ARG753GLN of the TLR-2 gene, Leu412Phe of TLR-3, Asp299Gly 
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Materials and methods: 112 patients with influenza were examined (63 patients with uncomplicated course and 49 with influenza-associated pneumonia). The genotyping 
of the polymorphic site of ARG753GLN of the TLR-2 gene, Asp299Gly of the TLR-4 gene, and Leu412Phe of the TLR-3 gene was carried out by polymerase chain reaction using 
oligonucleotide primers.
Results: It has found that the prevalence of the mutant allele 299Gly of TLR-4 in patients with uncomplicated influenza is 6.4 %, with influenza- associated pneumonia – 7.1 %, 
which exceeds the population control indicators by 3.8-4.3 times (1.7 %, p<0.05). Mutant allele 412Phe of TLR-3 is significantly more common in patients with influenza-
associated pneumonia (42.9%), as compared with uncomplicated influenza (24.6%, p<0.01) and healthy people (30.0%, p<0.05). The increased risk of influenza development 
is associated with the Asp/Gly genotype of TLR-4 (OR=4.22) and combination of mutant genotypes Leu/Phe and Phe/Phe of TLR-3 with Asp/Gly of TLR-4 and Arg/Gln of TLR-2 
(OR=15.0); influenza-associated pneumonia − with genotype Phe/Phe of TLR-3 (OR=4.5). 
Conclusions: It has been found out that among patients with influenza and influenza-associated pneumonia, the mutant allele 299Gly of TLR-4 and combinations of 
polymorphisms Arg753Gln of TLR-2, Leu412Phe of TLR-3, Asp299Gly of TLR-4 are detected reliably more often. The frequency of the mutant allele 412Phe of TLR-3 is higher 
among patients with influenza-associated pneumonia. Markers of increased risk of influenza are 299Gly allele and genotype Asp/Gly of TLR-4 and the combination of mutant 
genotypes Leu/Phe and Phe/Phe of TLR-3 with Asp/Gly of TLR-4 and Arg/Gln of TLR-2; for influenza-associated pneumonia − allele 412Phe and genotype Phe/Phe of TLR-3. 
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severity of the course of the infectious process, which acquires 
the nature of the systemic inflammatory response [10]. 
Taking into account the data of scientific literature, which 
indicates that susceptibility to infectious agents is geneti-
cally determined, the search for markers associated with 
the development of influenza and its complications among 
alleles of the TLR genes is a relevant task, the solution of 
which will allow us to predict the severity of the course 
and consequences of this pathology. 
THE AIM
The aim of the research is to examine the prevalence and 
determine the prognostic significance of polymorphism 
Arg753Gln of the TLR-2 gene, Leu412Phe of the TLR-3 
gene, Asp299Gly of the TLR-4 gene in influenza. 
MATERIALS AND METHODS
In order to achieve this aim, 112 patients were examined, out 
of them – 63 with uncomplicated course of the disease and 
49 with influenza-associated pneumonia. The patients were 
treated at the regional clinical infectious disease hospital 
(Poltava, Ukraine), in the epidemiologic season of 2009-
2014, among them 55 women (49.1%), 57 men (50.9%), 
aged from 17 to 61 years (mean age 34.4 ± 1.38). Most of 
the examined patients (76.8%) are young and middle-aged 
people. The population control group to study the prevalence 
of the Arg753Gln polymorphism of the TLR-2 gene and As-
p299Gly of TLR-4 was 90, for the Leu412Phe of TLR-3 – 80 
apparently healthy residents of Poltava region. 
The study included patients of both sexes, aged ≥18 years 
with laboratory- diagnosed influenza, who did not belong 
to the risk groups of the complications of this disease 
(pregnant women, patients with diabetes mellitus, obesity, 
chronic diseases of the lungs and heart, liver, kidneys, as 
well as persons of elderly age groups, etc.). Exclusion crite-
ria were age <18 years, negative results of laboratory tests 
(serological and molecular biology) for influenza, the pres-
ence of risk factors for the development of complications. 
All studies were conducted after the signing of the in-
formed consent by patients. The study was approved by the 
Commission on Ethical Issues and Bioethics of the Higher 
State Educational Establishment of Ukraine «Ukrainian 
Medical Stomatological Academy» (Approval No. 350). 
Influenza was diagnosed on the basis of characteristic 
clinical and epidemiological data and confirmed by the 
results of laboratory tests (serological and molecular biolo-
gy). The A/H1N1 virus has been isolated in 39.3%, A/H3N2 
– in 35.7%, A/H2N2 – in 0.9%, B – in 21.4%. Mixed-forms 
were represented by the combination of antigenic variants 
of influenza A viruses (H1N1 + H3N2) (1.8%), A/H1N1 
and B (0.9%) viruses that were registered in patients with 
influenza-associated pneumonia. 
The diagnosis of pneumonia was verified according to the rec-
ommendations of the European Respiratory Society (ERS, 2011) 
and the Order of Ministry of Public Health of Ukraine No. 128 
as of March 19, 2007 «On Approval of Clinical Protocols for the 
Provision of Medical Service in the Specialty «Pulmonology». 
To determine polymorphism ARG753GLN of TLR-2, As-
p299Gly of TLR-4, and Leu412Phe of TLR-3, we collected 
the samples of patients peripheral blood (2 ml) in the vials 
with ethylene diamine tetraacetic acid (EDTA) which were 
stored at -20°C and transported for testing in the laboratory 
(Research Institute of Genetic and Immunological Foun-
dations of Pathology and Pharmacogenetics, «Ukrainian 
Medical Stomatological Academy» Poltava, Ukraine). 
Genomic DNA was isolated using the «Kit for DNA/RNA 
isolation from serum or plasma» (LitTech, Russia). 
Polymorphic area Arg753Gln of the TLR-2 gene and 
Asp299Gly of TLR-4 were amplified at the «Tertsik» am-
plifier («DNA-technology», Russia), by PCR using specific 
oligonucleotide primers for the TLR-2 gene: 753TLR2F, 
5'-GAGTGGTGCAAGTATGAACTGGA-3'; and 753TL-
R2R, 5'-TCCCAACTAGACAAAGACTGGTCT-3', for 
TLR-4: 299TLR4F, 5’-GATTAGCATACTTAGACTAC-
TACCTCCATG-3’; and 299TLR4R, 5’-GATCAACTTCT-
GAAAAAGCATTCCCAC-3’.
The amplification programs for the TLR-4 and TLR-2 
genes included: initial denaturation at 95°C for 5 minutes, 
32 cycles: 95°С for 30 seconds, ignition at 58°C, 60 seconds, 
chain elongation at 72°C, 60 seconds, the program was 
completed with final elongation at 72°C, 3 min. 
To identify the alleles of the TLR-4 gene, we applied 
restriction analysis of amplicons using restriction endonu-
clease Bsp19 (SibEnzim, Russia), for TLR-2 − endonuclease 
restriction Pst I (SibEnzim, Russia) at 37°C. As a result of the 
restriction, fragments of 263 bp and 222 bp were obtained for 
the Asp299Gly polymorphism and 300 bp for Arg753Gln. 
To determine the alleles of the Leu412Phe polymorphic 
site of the TLR-3, genomic DNA gene was isolated from 
peripheral blood leukocytes using the reagent kit of «DNA-
EXPRESS-blood» (LitTech, Russia). The amplification 
program for the TLR-3 gene included initial denaturation 
at 93°C for 60 seconds, 35 cycles: 93°10 seconds, ignition 
at a specific temperature of 64°C for each pair of primers, 
10 seconds, chain elongation at 72°C, 20 seconds, final 
elongation at 72°C, 60 seconds. 
The breakdown products of the polymorphic site of the 
TLR-4, TLR-2 genes were detected by electrophoresis in 
the 3% agarose gel in 1 TBE (50 mM tris-H3PO and 2 mM 
EDTA, PH = 8.0), for 2 hours at a voltage of 2 V 1 cm of gel; 
TLR-3 − in 1 x tris-acetate (TAE) buffer, prepared from 50 
x TAE buffer (0.04M tris-acetate, 0.002M EDTA, pH = 8.3) 
at a voltage of 10-15 V per 1 cm of gel. Gels were stained 
with 1% solution of ethidium bromide with subsequent 
visualization of the results in UV light. 
In mathematical processing of the data, we used the 
software «Statistica for Windows 7.0» (StatSoft Inc, USA) 
and MS Excel. The distribution of investigated polymor-
phic genotypes was checked for compliance with the Har-
dy-Weinberg equilibrium using the χ2 criterion. Compari-
son of the frequencies of genotypes and alleles between the 
studied groups was conducted using Fisher’s exact test. The 
differences were considered reliable at p<0.05. The relative 
risk of disease and complications were evaluated using OR 
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rate with defining 95% confidence interval (CI). The indi-
cator OR=1 was considered as a lack of association; OR>1 
− as a positive association (“predisposition”), OR<1 − as a 
negative association of allele or genotype with the disease. 
RESULTS AND DISCUSSION
As a result of the molecular-genetic examination of 
112 patients with influenza, the following genotypes of 
the studied TLRs were obtained: TLR-2 − Gln753Gln, 
Arg753Gln; TLR-3 − Leu412Leu, Leu412Phe, Phe412P-
he; TLR-4 − Asp299Asp, Asp299Gly. The distribution of 
genotypes corresponded to the expected Hardy-Weinberg 
equilibrium in the groups of patients with influenza, in-
fluenza-associated pneumonia and healthy people for all 
investigated polymorphic loci. 
In analyzing the results of the study, it was found that 
among the patients with influenza, the Leu412Phe poly-
morphism of the TLR-3 gene, Asp299Gly of TLR-4, as 
well as their combination with Arg753Gln of TLR-2 were 
determined more often, as compared with apparently 
healthy ones. Distribution in frequencies of genotypes and 
alleles of the Leu412Phe polymorphism of TLR-3 among 
the examined groups are presented in Table 1. 
As can be observed from the data presented in Table 1, the 
prevalence of the mutant homozygous genotype Phe/Phe 
of TLR-3 and allele 412Phe was significantly higher among 
patients with influenza-associated pneumonia by 3.7 and 1.4 
times (p=0.03 and p=0.04), as compared with healthy subjects 
and by 3.8 and 1.7 times (p=0.02 and p=0.004) − as compared 
to patients with influenza. The presence of the 412Phe mutant 
allele in the genome of patients with influenza and homozy-
gous genotype Phe/Phe by 2.3 and 4.5 times increases the risk 
of influenza-associated pneumonia (OR=2.3; 95% CI: 1.3-4.06 
and OR=4.5; 95% CI: 1.15-17, 65, respectively). 
A comparative analysis of the frequencies in genotypes 
and alleles of the Asp299Gly polymorphism of the TLR-4 
gene between the examined groups of patients and the 
healthy subjects is presented in Table 2.
Regarding the Asp299Gly polymorphism of the TLR-4 
gene, it has been found that frequency of the heterozygous 
genotype Asp/Gly and the mutant allele 299Gly is higher 
among patients with influenza by 3.8 (p<0.05), with in-
fluenza-associated pneumonia by 4.3 times (p=0.03), as 
compared to healthy subjects. In carriers of the 299Gly 
allele of the TLR-4 gene, there was a higher risk of influenza 
by 4.0 times (OR=4.0; 95% CI: 1.04-15.39) than in those 
with the Asp299Asp genotype.
 When comparing the frequencies of genotype and alleles 
of the Arg753Gln polymorphism of TLR-2, there were no 
statistically significant differences between the examined 
groups. Frequency of the heterozygous genotype Arg/Gln 
of TLR-2 among the patients with influenza was 4.8%, 
influenza-associated pneumonia − 6.1%, healthy − 3.3% 
(p>0.05), and the 753Arg alleles – 2.4%, 3.1% and 1.7% 
(p>0.05) respectively. 
Table 1. Distribution in frequencies of genotypes and alleles of the Leu412Phe polymorphism of the TLR-3 gene among patients with influenza, influenza-
associated pneumonia and healthy subjects, abs. number (%)
Genotype and 
alleles 
Healthy
subjects 
n = 80 
Groups of patients 
F 
p≤
 
OR (95 % CI) uncomplicated 
influenza 
n = 63 
influenza-associated 
pneumonia 
n = 49 
Leu/Leu 36 (45.0) 35 (55.5) 16 (32.7) 
0.2403 a 
0.1973 b 
0.0216 d 
1.53 (0.79-2.97) a 
0.59 (0.28-1.24) b 
0.39 (0.18-0.84) d 
Leu/Phe 40 (50.0) 25 (39.7) 24 (48.9) 
0.2399 a 
0.9999 b 
0.3437 d 
0.66 (0.34-1.28) a 
0.96 (0.47-1.95) b 
1.46 (0.69-3.1) d 
Phe/Phe 4 (5.0) 3 (4.8) 9 (18.4) 
1.00 a 
0.0309 b* 
0.0299 d* 
0.95 (0.2-4.41) a 
4.28 (1.24-14.75) b 
4.5 (1.15-17.65) d 
Leu 112 (70.0) 95 (75.4) 
56 
(57.1) 
0.3519 a
0.0434 b 
0.0042 d 
1.31 (0.77-2.23) a 
0.57 (0.34-0.96) b 
0.44 (0.25-0.77) d 
Phe 48 (30.0) 
31 
(24.6) 
42 
(42.9) 
0.3519 a 
0.0434 b* 
0.0042 d* 
0.76 (0.45 − 1.29) a 
1.75 (1.04-2.95) b 
2.3 (1.3-4.06) d 
Note: here and in Table 1, 2, p is the level of significance obtained by Fischer’s exact test for differences in the frequencies of genotypes and alleles between: 
a – healthy subjects and patients with uncomplicated influenza; b − healthy subjects and patients with influenza-associated pneumonia; d − patients 
with uncomplicated influenza and influenza-associated pneumonia. 
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The absence of mutant homozygous genotypes 
Arg753Arg of TLR-2 and Gly299Gly of TLR-4 was noted 
for both patients with influenza and healthy subjects, which 
corresponds to the data of scientific literature about the low 
frequency of their prevalence in the population [11, 12]. 
Combinations of mutant genotypes of TLR-2, TLR-3, 
TLR-4 was only registered in patients with influenza 
(11.1%, p<0.01) and influenza-associated pneumonia 
(14.3%, p<0.003), and it was not detected in healthy sub-
jects. Most (80.0%) combinations included polymorphical-
ly modified genotypes of TLR-3. The most common, both 
among patients with influenza and influenza-associated 
pneumonia, was the combination of the heterozygous 
genotype Leu/Phe of TLR-3 with Asp/Gly of TLR-4 (6.3% 
and 10.2% respectively). 
It has been established that the presence of mutant geno-
types of TLR-3 in the genome in combination with TLR-2 
and TLR-4 by 15.0 times (OR=15.0; 95% CI: 1.83-286.93) 
increases the risk of influenza development in the carriers 
of these mutations. 
Thus, we have proved that the presence of PheLeu412 
polymorphisms of the TLR-3 gene, Asp299Gly of TLR 4 
and their combinations with Arg753Gln of TLR-2 make 
it possible to predict the risk for development of influenza 
and influenza-associated pneumonia. Previous studies 
have shown that polymorphism of TLR genes causes 
the predisposition to a variety of diseases, as well as the 
severity of their course. Hence, at present, the Asp299Gly 
polymorphism of the TLR-4 gene is associated with the 
development of hematogenous osteomyelitis, systemic can-
didiasis, bronchial asthma, sepsis, caused by gram-negative 
bacteria, respiratory viral infections in children [13-17]. 
The association between Arg753Gln of TLR-2 has been 
established with increased risk for development of tuber-
culosis, acute rheumatic fever in children, septic shock, 
caused by gram-positive bacteria, CMV-infections in 
patients after liver transplantation [18-21]. In the study 
by Nachtigall I. et al. [22], the connection between the 
Arg753Gln polymorphism of the TLR-2 gene and the 
Asp299Gly of the TLR-4 gene with rapid progression and 
severe sepsis has been proven. 
A number of scientific studies link the SNP Leu412Phe 
polymorphism of TLR-3 with the development of subacute 
sclerosing panencephalitis in the cortex, myocarditis and 
dilated cardiomyopathy in enterovirus infection, severe 
course of atypical pneumonia with the development of 
GERD, induced by the coronavirus [23-25]. 
Thus, active research of genetic variability of TLR in 
the last decade produces evidence that polymorphism of 
single nucleotides through the formation of specific gene 
alleles makes an important contribution to the individual 
features of development of protective reactions, as well as 
susceptibility to a variety of diseases. 
CONCLUSIONS 
1.  The frequency of the Asp/Gly heterozygous genotype 
of TLR-4 in patients with influenza constituted 12.7%, 
with influenza-associated pneumonia – 14.3%, which 
exceeded the indicators of population control by 3.8-4.3 
times (3.3 %, p<0.05). 
2.  The homozygous genotype Phe/Phe of TLR-3 in patients 
with influenza-associated pneumonia was determined 
with the frequency of 18.4 %, which exceeded the rates 
of patients with uncomplicated influenza (4.8%, p=0.02) 
and healthy subjects (5.0%, p=0.03). 
3.  The combination of mutant genotypes of TLR-2, TLR-3, 
TLR-4 was not detected in healthy subjects and was deter-
mined in patients with influenza and influenza-associated 
pneumonia with the frequency from 11.1% to 14.3% (p<0.05).
4.  The presence of polymorphically modified genotypes of 
TLR-4, TLR-3 and their combinations with TLR-2 allows 
Table 2. Distribution of genotypes and alleles of the Asp299Gly polymorphism of the TLR-4 gene among patients with influenza, influenza-associated 
pneumonia and healthy subjects, abs. number (%)
Genotype 
and alleles
Healthy 
subjects
n=90 
Groups of patients 
p (F) OR (95 % CI) uncomplicated 
influenza 
n=63 
influenza-associated 
pneumonia 
n=49 
Asp/Asp 87 (96.7) 55 (87.3) 42 (85.7) 
0.0516 a 
0.0334 b 
0.9999 d 
0.24 (0.06-0.93) a 
0.21 (0.05-0.84) b 
0.87 (0.29-2.6) d 
Asp/Gly 3 (3.3) 8 (12.7) 7 (14.3) 
0.0516 a* 
0.0324 b* 
0.9999 d 
4.22 (1.07-16.59) a 
4.95 (1.22-20.13) b 
1.15 (0.38-3.41) d 
Gly/Gly 0 (0.0) 0 (0.0) 0 (0.0) 0 0 
Asp 177 (98.3) 118 (93.6) 
91 
(92.9) 
0.0561 a 
0.0367 b 
0.9999 d 
0.25 (0.06-0.96) a 
0.22 (0.06-0.87) b 
0.88 (0.31-2.52) d 
Gly 3 (1.7) 8 (6.4) 7 (7.1) 
0.0561 a* 
0.0367 b* 
0.9999 d 
4 (1.04-15.39) a 
4.54 (1.15-17.97) b 
1.13 (0.4-3.24) d 
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us to predict the risk for development of influenza and 
influenza-associated pneumonia. Markers of increased 
risk of influenza are the 299Gly allele and the Asp/Gly 
genotype of TLR-4 (OR=4.0 and OR=4.22, respectively) 
and the combination of mutant genotypes Leu/Phe and 
Phe/Phe of TLR-3 with Asp/Gly of TLR-4 and Arg/Gln 
of TLR-2 (OR=15.0); influenza-associated pneumonia 
– the 412Phe allele and the Phe/Phe genotype of TLR-3 
(OR=2.3 and OR=4.5, respectively). 
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